Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections

Mikolajczyk RT, Horn J, Damm O, Kaufmann AM, Kretzschmar MEE (2012)
JNCI Journal of the National Cancer Institute 104(2): 163.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ;
Erscheinungsjahr
Zeitschriftentitel
JNCI Journal of the National Cancer Institute
Band
104
Zeitschriftennummer
2
Seite
163
ISSN
eISSN
PUB-ID

Zitieren

Mikolajczyk RT, Horn J, Damm O, Kaufmann AM, Kretzschmar MEE. Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections. JNCI Journal of the National Cancer Institute. 2012;104(2):163.
Mikolajczyk, R. T., Horn, J., Damm, O., Kaufmann, A. M., & Kretzschmar, M. E. E. (2012). Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections. JNCI Journal of the National Cancer Institute, 104(2), 163. doi:10.1093/jnci/djr517
Mikolajczyk, R. T., Horn, J., Damm, O., Kaufmann, A. M., and Kretzschmar, M. E. E. (2012). Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections. JNCI Journal of the National Cancer Institute 104, 163.
Mikolajczyk, R.T., et al., 2012. Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections. JNCI Journal of the National Cancer Institute, 104(2), p 163.
R.T. Mikolajczyk, et al., “Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections”, JNCI Journal of the National Cancer Institute, vol. 104, 2012, pp. 163.
Mikolajczyk, R.T., Horn, J., Damm, O., Kaufmann, A.M., Kretzschmar, M.E.E.: Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections. JNCI Journal of the National Cancer Institute. 104, 163 (2012).
Mikolajczyk, Rafael T., Horn, Johannes, Damm, Oliver, Kaufmann, Andreas M., and Kretzschmar, Mirjam E. E. “Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections”. JNCI Journal of the National Cancer Institute 104.2 (2012): 163.

2 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Cost-effectiveness of human papillomavirus vaccination in Germany.
Damm O, Horn J, Mikolajczyk RT, Kretzschmar MEE, Kaufmann AM, Deleré Y, Ultsch B, Wichmann O, Krämer A, Greiner W., Cost Eff Resour Alloc 15(), 2017
PMID: 28878573
The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model.
Matthijsse SM, van Rosmalen J, Hontelez JA, Bakker R, de Kok IM, van Ballegooijen M, de Vlas SJ., PLoS One 10(2), 2015
PMID: 25642941

5 References

Daten bereitgestellt von Europe PubMed Central.

Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Gonzalez P, Quint W, van Doorn LJ, Sherman ME, Xhenseval V, Herrero R, Hildesheim A; Costa Rican Vaccine Trial Group, Alfaro M, Barrantes M, Bratti MC, Cardenas F, Cortes B, Espinoza A, Estrada Y, Gonzalez P, Guillen D, Herrero R, Jimenez SE, Morales J, Morera LA, Perez E, Porras C, Rodriguez AC, Villegas M, Freer E, Bonilla J, Silva S, Atmella I, Ramirez M, Macklin N, Hildesheim A, Lowy DR, Schiffman M, Schiller JT, Sherman M, Solomon D, Wacholder S, Pinto L, Garcia-Pineres A, Eklund C, Hutchinson M, Quint W, van Doorn LJ, Bougelet C., J. Natl. Cancer Inst. 102(21), 2010
PMID: 20944077
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.
Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA., J. Infect. Dis. 181(6), 2000
PMID: 10837170
Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.
Trottier H, Mahmud S, Prado JC, Sobrinho JS, Costa MC, Rohan TE, Villa LL, Franco EL., J. Infect. Dis. 197(10), 2008
PMID: 18419547
The natural history of type-specific human papillomavirus infections in female university students.
Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutlee F, Franco EL., Cancer Epidemiol. Biomarkers Prev. 12(6), 2003
PMID: 12814991

AUTHOR UNKNOWN, Vaccine 25(), 2007

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 22232131
PubMed | Europe PMC

Suchen in

Google Scholar